Assessing interactions between mdm-2, p53, and bcl-2 as prognostic variables in muscle-invasive bladder cancer treated with neo-adjuvant chemotherapy followed by locoregional surgical treatment Academic Article uri icon

Overview

MeSH Major

  • Neoadjuvant Therapy
  • Neoplasm Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • Proto-Oncogene Proteins c-mdm2
  • Tumor Suppressor Protein p53
  • Urinary Bladder Neoplasms

abstract

  • The cooperative effects of phenotypes determined by mdm-2, p53, and bcl-2 expression may predict survival in patients with muscle-invasive TCC of the bladder.

publication date

  • November 2006

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1093/annonc/mdl289

PubMed ID

  • 16984978

Additional Document Info

start page

  • 1677

end page

  • 86

volume

  • 17

number

  • 11